UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Pragmatic Study Evaluating NEPA Versus Aprepitant for Prevention of Chemotherapy‐Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy

The oncologist (Dayton, Ohio), 2021-10, Vol.26 (10), p.e1870-e1879

2021

Volltextzugriff (PDF)

Molecular intrinsic subtypes, genomic, and immune landscapes of BRCA-proficient but HRD-high ER-positive/HER2-negative early breast cancers

Breast cancer research : BCR, 2022-11, Vol.24 (1), p.1-80, Article 80

2022

Volltextzugriff (PDF)

Real-world prevalence, treatment and survival of “high risk” early breast cancer, with mandatory testing of gBRCA1/2 mutation according to the OlympiA trial inclusion criteria: Data from a population-based registry

Breast (Edinburgh), 2024-12, Vol.78, p.103789, Article 103789

2024

Volltextzugriff (PDF)

Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer

Cancers, 2023-02, Vol.15 (4), p.1299

2023

Volltextzugriff (PDF)

Taxane rechallenge during metastatic disease in HER-2 negative breast cancer patients: Clinical activity, tolerance and survival results

Breast (Edinburgh), 2023-04, Vol.68, p.149-156

2023

Volltextzugriff (PDF)

Trastuzumab-emtansine induced pleural and pericardial effusions

Journal of oncology pharmacy practice, 2021-12, Vol.27 (8), p.2041-2044

2021

Volltextzugriff (PDF)

Management of Cancer-Associated Thrombosis in France: A National Survey among Vascular Disease and Supportive Care Specialists

Cancers, 2022-08, Vol.14 (17), p.4143

2022

Volltextzugriff (PDF)

Carboplatin and Etoposide for the Treatment of Metastatic Prostate Cancer with or without Neuroendocrine Features: A French Single-Center Experience

Cancers, 2024-01, Vol.16 (2), p.280

2024

Volltextzugriff (PDF)

Symptomatic Treatment With Lanreotide Microparticles in Inoperable Bowel Obstruction Resulting From Peritoneal Carcinomatosis: A Randomized, Double-Blind, Placebo-Controlled Phase III Study

Journal of clinical oncology, 2012-12, Vol.30 (35), p.4337-4343

2012

Volltextzugriff (PDF)

Population Pharmacokinetics of Palbociclib in a Real-World Situation

Pharmaceuticals (Basel, Switzerland), 2021-03, Vol.14 (3), p.181

2021

Volltextzugriff (PDF)

Pharmacokinetic/Pharmacodynamic Model of Neutropenia in Real-Life Palbociclib-Treated Patients

Pharmaceutics, 2021-10, Vol.13 (10), p.1708

2021

Volltextzugriff (PDF)

Efficacy of platinum-based chemotherapy in metastatic breast cancer and HRD biomarkers: utility of exome sequencing

NPJ breast cancer, 2022-03, Vol.8 (1), p.28-28, Article 28

2022

Volltextzugriff (PDF)

The official French guidelines to protect patients with cancer against SARS-CoV-2 infection

The lancet oncology, 2020-05, Vol.21 (5), p.619-621

2020

Volltextzugriff (PDF)

Factors influencing the use of thromboprophylaxis in cancer outpatients: CAT AXIS, a case-vignette study on clinical practice

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e18276-e18276

2017

Volltextzugriff (PDF)

Extended Anticoagulant Treatment with Full- or Reduced-Dose Apixaban in Patients with Cancer-Associated Venous Thromboembolism: Rationale and Design of the API-CAT Study

Thrombosis and haemostasis, 2022-04, Vol.122 (4), p.646-656

2022

Volltextzugriff (PDF)

Anticoagulant treatment of cancer-associated thromboembolism

Archives of cardiovascular diseases, 2024-01, Vol.117 (1), p.29-44

2024

Volltextzugriff (PDF)

Prognostic stratification ability of the CPS+EG scoring system in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy

European journal of cancer (1990), 2024-05, Vol.202, p.114037-114037, Article 114037

2024

Volltextzugriff (PDF)

Management of venous thromboembolism in cancer patients: the economic burden of hospitalizations

Supportive care in cancer, 2016-10, Vol.24 (10), p.4105-4112

2016

Volltextzugriff (PDF)

Treatment of cancer-associated venous thromboembolism in patients under palliative care

Archives of cardiovascular diseases, 2024-01, Vol.117 (1), p.94-100

2024

Volltextzugriff (PDF)

Unmet needs and barriers in venous thromboembolism education and awareness among people living with cancer: a global survey

Journal of thrombosis and haemostasis, 2024-07, Vol.22 (7), p.1973-1983

2024

Volltextzugriff (PDF)

Care pathways for patients with cancer-associated thrombosis: From diagnosis to long-term follow-up

Archives of cardiovascular diseases, 2024-01, Vol.117 (1), p.6-15

2024

Volltextzugriff (PDF)

Erratum to: Anémie et cancer

Oncologie (Paris, France), 2011-12, Vol.13 (12), p.873-873

Mayeur, Didier

2011

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(64)

Publikationsform

Sprache

Englisch
(59)
Französisch
(19)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

A Pragmatic Study Evaluating NEPA Versus Aprepitant for Prevention of Chemotherapy‐Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy

Molecular intrinsic subtypes, genomic, and immune landscapes of BRCA-proficient but HRD-high ER-positive/HER2-negative early breast cancers

Real-world prevalence, treatment and survival of “high risk” early breast cancer, with mandatory testing of gBRCA1/2 mutation according to the OlympiA trial inclusion criteria: Data from a population-based registry

Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer

Taxane rechallenge during metastatic disease in HER-2 negative breast cancer patients: Clinical activity, tolerance and survival results

Trastuzumab-emtansine induced pleural and pericardial effusions

Management of Cancer-Associated Thrombosis in France: A National Survey among Vascular Disease and Supportive Care Specialists

Carboplatin and Etoposide for the Treatment of Metastatic Prostate Cancer with or without Neuroendocrine Features: A French Single-Center Experience

Symptomatic Treatment With Lanreotide Microparticles in Inoperable Bowel Obstruction Resulting From Peritoneal Carcinomatosis: A Randomized, Double-Blind, Placebo-Controlled Phase III Study

PROPERTY: study protocol for a randomized, double-blind, multicenter placebo-controlled trial assessing neurotoxicity in patients with metastatic gastrointestinal cancer taking PHYCOCARE® during oxaliplatin-based chemotherapy

Population Pharmacokinetics of Palbociclib in a Real-World Situation

Pharmacokinetic/Pharmacodynamic Model of Neutropenia in Real-Life Palbociclib-Treated Patients

Efficacy of platinum-based chemotherapy in metastatic breast cancer and HRD biomarkers: utility of exome sequencing

The official French guidelines to protect patients with cancer against SARS-CoV-2 infection

Factors influencing the use of thromboprophylaxis in cancer outpatients: CAT AXIS, a case-vignette study on clinical practice

Extended Anticoagulant Treatment with Full- or Reduced-Dose Apixaban in Patients with Cancer-Associated Venous Thromboembolism: Rationale and Design of the API-CAT Study

Anticoagulant treatment of cancer-associated thromboembolism

Subcutaneous Interleukin-2 and Interferon Alfa Administration in Patients With Metastatic Renal Cell Carcinoma: Final Results of SCAPP III, a Large, Multicenter, Phase II, Nonrandomized Study With Sequential Analysis Design—The Subcutaneous Administration Propeukin Program Cooperative Group

Prognostic stratification ability of the CPS+EG scoring system in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy

Management of venous thromboembolism in cancer patients: the economic burden of hospitalizations

Treatment of cancer-associated venous thromboembolism in patients under palliative care

Unmet needs and barriers in venous thromboembolism education and awareness among people living with cancer: a global survey

Care pathways for patients with cancer-associated thrombosis: From diagnosis to long-term follow-up

Seroprevalence of SARS-CoV-2 among the staff and patients of a French cancer centre after first lockdown: The canSEROcov study

Erratum to: Anémie et cancer

Suchergebnisse filtern